THE INTERLEUKIN-1B INHIBITOR CANAKINUMAB FOR REFRACTORY STILL'S DISEASE: LONG-TERM EXPERIENCE IN 50 CONSECUTIVE PATIENTS

被引：0
|
作者：
Laskari, K. [1 ]
Athanassiou, P. [2 ]
Georgiadis, A.
Gerodimos, C.
Gkoni, G. [3 ]
Daoussis, D. [4 ]
Dimitroulas, T. [5 ]
Dimopoulou, D. [5 ]
Iliou, C.
Kallitsakis, I.
Karamitsos, D. [6 ]
Katsiari, C. [7 ]
Liossis, S. N.
Mavragani, C. [1 ]
Papagoras, C.
Pikazis, D. [1 ]
Raftakis, I. [8 ]
Sarikoudis, T.
Settas, L. [9 ]
Sidiropoulos, P. [10 ]
Soukera, D.
Theodorou, E. [11 ]
Tsatsani, P. [12 ]
Tsiakou, E.
Vassilopoulos, D.
Vlachoyiannopoulos, P. [1 ]
Vosvotekas, G.
Voulgari, P. V. [13 ]
Zakalka, M.
Tektonidou, M. [1 ]
Sfikakis, P. [1 ]
机构：
[1] NKUA Med Sch, Joint Rheumatol Program, Athens, Greece
[2] St Pauls Hosp, Dept Rheumatol, Thessaloniki, Greece
[3] Metropolitan Hosp, Athens, Greece
[4] Univ Patras, Dept Rheumatol, Patras, Greece
[5] Aristotle Univ Thessaloniki, Dept Internal Med 4, Thessaloniki, Greece
[6] Evangelismos Med Ctr, Rheumatol Clin, Athens, Greece
[7] Thessaly Univ, Dept Rheumatol, Larisa, Greece
[8] Asklepion Hosp, Rheumatol Clin, Athens, Greece
[9] Aristotle Univ Thessaloniki, Rheumatol Sect, Dept Internal Med 1, Thessaloniki, Greece
[10] Univ Crete, Dept Rheumatol Clin Immunol & Allergy, Iraklion, Greece
[11] 251 Air Force Gen Hosp, Dept Rheumatol, Athens, Greece
[12] KAT Gen Hosp, Dept Rheumatol, Athens, Greece
[13] Univ Ioannina, Rheumatol Clin, Ioannina, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.5217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0493
引用
收藏
页码：841 / 841
页数：1
相关论文
共 50 条
  • [1] Interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms in Korean patients with adult-onset Still's disease
    Youm, J-Y
    Woo, J-H
    Kim, T-H
    Bae, S-C
    Yoo, D-H
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (05) : 390 - 393
  • [2] The Interleukin-1 Inhibitor Canakinumab for Familial Mediterranean Fever: Long-Term Beneficial Effect in a Cohort of 13 Patients
    Laskari, Katerina
    Boura, Panagiota
    Dalekos, George N.
    Garyfallos, Alexandros
    Karokis, Dimitrios
    Pikazis, Dimitrios
    Settas, Loukas
    Skarantavos, Grigoris
    Tsitsami, Elena
    Sfikakis, Petros P.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] THE INTERLEUKIN-1 INHIBITOR CANAKINUMAB FOR FAMILIAL MEDITERRANEAN FEVER: LONG-TERM BENEFICIAL EFFECT IN A COHORT OF 14 PATIENTS
    Laskari, K.
    Boura, P.
    Dalekos, G. N.
    Garyfallos, A.
    Karokis, D.
    Pikazis, D.
    Settas, L.
    Skarantavos, G.
    Tsitsami, E.
    Sfikakis, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 618 - 619
  • [4] The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease
    Kontzias, Apostolos
    Efthimiou, Petros
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (02) : 201 - 205
  • [5] LONG-TERM THERAPY WITH CANAKINUMAB IN TWO PATIENTS WITH REFRACTORY CHRONIC AUTOINFLAMMATORY ARTHRITIS
    Skendros, P.
    Papagoras, C.
    Oikonomou, A.
    Apostolidou, E.
    Konstantinidis, T.
    Kambas, K.
    Mitroulis, I.
    Ritis, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 318 - 318
  • [6] EFFICACY OF LONG-TERM TREATMENT WITH BIOLOGIC AGENTS IN REFRACTORY ADULT ONSET STILL'S DISEASE: A SINGLE CENTRE EXPERIENCE ON 16 PATIENTS
    Della Torre, E.
    Franchini, S.
    Baldissera, E.
    Cavalli, G.
    Bozzolo, E. P.
    Sabbadini, M. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 286 - 286
  • [7] Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behcet disease uveitis and concomitant bladder papillary carcinoma
    Orlando, Ida
    Vitale, Antonio
    Rigante, Donato
    Lopalco, Giuseppe
    Fabiani, Claudia
    Cantarini, Luca
    INTERNAL MEDICINE JOURNAL, 2017, 47 (09) : 1086 - 1088
  • [8] Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients
    Laskari, K.
    Tekonidu, M. G.
    Katsiari, C.
    Athanassiou, P.
    Dimopoulou, D.
    Gerodimos, C.
    Salamaliki, C.
    Papagoras, C.
    Settas, L.
    Vassilopoulos, D.
    Voulgari, P. V.
    Zakalka, M.
    Georgiadis, A.
    Gkoni, G.
    Daoussis, D.
    Dimitroulas, T.
    Iliou, C.
    Kallitsakis, I
    Grika, E. P.
    Mavragani, C.
    Pikazis, D.
    Raftakis, J.
    Sarikoudis, T.
    Kougkas, N.
    Soukera, D.
    Theodorou, E.
    Tsatsani, P.
    Tsiakou, E.
    Vlachoyiannopoulas, P.
    Vosvotekas, G.
    Sfikakis, P. P.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (01) : 137 - 143
  • [9] Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation
    Wider, C.
    Pollo, C.
    Bloch, J.
    Burkhard, P. R.
    Vingerhoets, F. J. G.
    PARKINSONISM & RELATED DISORDERS, 2008, 14 (02) : 114 - 119
  • [10] Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience
    Wils, P.
    Bouhnik, Y.
    Michetti, P.
    Flourie, B.
    Brixi, H.
    Bourrier, A.
    Allez, M.
    Duclos, B.
    Serrero, M.
    Buisson, A.
    Amiot, A.
    Fumery, M.
    Roblin, X.
    Peyrin-Biroulet, L.
    Filippi, J.
    Bouguen, G.
    Abitbol, V.
    Coffin, B.
    Simon, M.
    Laharie, D.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S43 - S43
12345